Are you Dr. McGowan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
800 Ridgeview Dr
Horsham, PA 19044Phone+1 215-325-5329
Summary
- Dr. Tracy McGowan, MD is a nephrologist in Horsham, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Nephrology, 1996 - 1999
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1992 - 1995
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1992
Certifications & Licensure
- PA State Medical License 1993 - 2024
Publications & Presentations
PubMed
- 765 citationsLong-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming gro...Fuad N. Ziyadeh, Brenda B. Hoffman, Dong Cheol Han, M. Carmen Iglesias-de la Cruz, Soon Won Hong
Proceedings of the National Academy of Sciences of the United States of America. 2000-07-05 - 227 citationsIncreased renal production of transforming growth factor-beta1 in patients with type II diabetes.Kumar Sharma, Fuad N. Ziyadeh, Bashar Alzahabi, Tracy A. McGowan, Shiv Kapoor
Diabetes. 1997-05-01 - 132 citationsPirfenidone Is Renoprotective in Diabetic Kidney DiseaseSatish P. RamachandraRao, Yanqing Zhu, Timothy Ravasi, Tracy A. McGowan, Irene Toh
Journal of the American Society of Nephrology. 2009-08-01
Press Mentions
- New ERLEADA® (Apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)February 14th, 2022
- (Apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence RatesSeptember 12th, 2021